Company facts
- Headquarters
- South San Francisco, California
- Most recent report
- 8-K, filed Aug 19, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1581280
- Fiscal year ends
- September
- Filer status
- Large accelerated filer
Financials 8 of 19
News 8 of 35
Prospectuses and Registrations 8 of 9
- 424B5 Prospectus supplement for an offering Aug 5, 2026
- 424B5 Prospectus supplement for an offering Aug 4, 2026
- S-3ASR Automatic shelf registration Jun 18, 2026
- S-8 Registration statement for an employee plan Feb 12, 2025
- S-8 Registration statement for an employee plan Nov 18, 2024
- S-8 Registration statement for an employee plan Nov 21, 2023
- S-8 Registration statement for an employee plan Aug 25, 2023
- S-3ASR Automatic shelf registration Jun 5, 2023
Proxies 5
Ownership 8 of 924
- 4 Insider reported a trade Sep 25, 2026
- 144 Notice of a proposed sale of restricted stock Sep 24, 2026
- 4 Insider reported a trade Sep 23, 2026
- 4 Insider reported a trade Sep 23, 2026
- 4 Insider reported a trade Sep 23, 2026
- 144 Notice of a proposed sale of restricted stock Sep 21, 2026
- 144 Notice of a proposed sale of restricted stock Sep 21, 2026
- 144 Notice of a proposed sale of restricted stock Sep 21, 2026
Other 8
- 424B7 Aug 19, 2026
- UPLOAD Comment letter from SEC staff Mar 5, 2026
- CORRESP Reply to SEC staff Feb 26, 2026
- UPLOAD Comment letter from SEC staff Feb 19, 2026
- 424B7 Feb 17, 2026
- ARS Annual report sent to shareholders Jan 6, 2026
- ARS Annual report sent to shareholders Jan 6, 2025
- ARS Annual report sent to shareholders Jan 5, 2024
Everything here comes from Twist Bioscience Corp's own filings on SEC EDGAR. The filing list is rechecked every hour.